| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/09/1997 | US5665758 6-Heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
| 09/09/1997 | US5665756 Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders |
| 09/09/1997 | US5665754 Phosphodiesterase inhibitors, antiinflammatory agents |
| 09/09/1997 | US5665747 Treating nervous system, psychological, and brain disorders |
| 09/09/1997 | US5665745 1,2,5-thiadiazole derivatives for treating diseases of central nervous system |
| 09/09/1997 | US5665743 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
| 09/09/1997 | US5665741 1,4-dihydropyridine-3,5-dicarboxylic acid esters in treatment of neuronal diseases |
| 09/09/1997 | US5665740 Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2,6-dimethyl-pyridine-3,5-dica rboxylate |
| 09/09/1997 | US5665737 Phosphodiesterase inhibitors |
| 09/09/1997 | US5665736 Antidepressants |
| 09/09/1997 | US5665733 3-phenylisoquinol-1(2H)-one derivatives their preparation and their therapeutic application |
| 09/09/1997 | US5665732 Indazole derivatives |
| 09/09/1997 | US5665729 Carbocyclic or heterocyclic fused dihydropyridines |
| 09/09/1997 | US5665725 Piperidine derivatives having anxiolytic effect |
| 09/09/1997 | US5665722 For treating and/or prevention of psychotic disorders |
| 09/09/1997 | US5665718 Anxiolytic, anticonvulsant, muscle relaxant, sedative, hypnotic agents |
| 09/09/1997 | CA1339452C Enantiomers of citalopram and derivatives thereof |
| 09/04/1997 | WO1997031949A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 09/04/1997 | WO1997031944A1 Fragments of cr1 and their use |
| 09/04/1997 | WO1997031941A2 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | WO1997031940A1 Isoquinolines useful as analgesics |
| 09/04/1997 | WO1997031918A1 Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type |
| 09/04/1997 | WO1997031916A1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands |
| 09/04/1997 | WO1997031906A1 Isoxazole derivatives |
| 09/04/1997 | WO1997031902A1 Quinoxaline derivatives useful in therapy |
| 09/04/1997 | WO1997031887A1 Aminotetralin derivatives and compositions and method of use thereof |
| 09/04/1997 | WO1997031636A1 Novel indole and benzothiazole derivatives |
| 09/04/1997 | DE19607395A1 Morphin- und Diamorphinsalze anionischer nicht-narkotischer Analgetika vom Typ der substituierten Carbonsäuren, Verfahren zu deren Herstellung, deren Verwendung und die diese Salze enthaltenden pharmazeutischen Präparate Morphine and diamorphine salts of anionic non-narcotic analgesics of the type substituted carboxylic acids, processes for their preparation, their use and the pharmaceutical preparations containing these salts |
| 09/04/1997 | CA2248269A1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands |
| 09/04/1997 | CA2247802A1 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | CA2247439A1 Isoxazole derivatives |
| 09/04/1997 | CA2246813A1 Novel indole and benzothiazole derivatives |
| 09/04/1997 | CA2244219A1 Isoquinolines useful as analgesics |
| 09/04/1997 | CA2198980A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/03/1997 | EP0792879A1 Hydrate for medicinal use |
| 09/03/1997 | EP0792874A1 Quinoxaline derivatives useful in therapy |
| 09/03/1997 | EP0792643A1 Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage |
| 09/03/1997 | EP0792642A1 Method of treating conditions with estrogen agonists |
| 09/03/1997 | EP0792641A1 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 09/03/1997 | EP0792640A2 Use of (E)-1-(4'-(2-alkylaminoethioxy)-phenyl)-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes for inhibiting pathological conditions |
| 09/03/1997 | EP0792638A1 Use of 1,1,2-triphenylbut-1-ene derivatives for the manufacture of a medicament for treating Alzheimer's disease |
| 09/03/1997 | EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
| 09/03/1997 | EP0792362A2 Sensory and motor neuron derived factor (smdf) |
| 09/03/1997 | EP0792350A1 Regulation of neural stem cell proliferation |
| 09/03/1997 | EP0792349A1 In vitro induction of dopaminergic cells |
| 09/03/1997 | EP0792292A2 Orphan receptor |
| 09/03/1997 | EP0792287A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 09/03/1997 | EP0792286A1 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein |
| 09/03/1997 | EP0792269A2 Certain substituted 1-aryl-3-piperazin-1'-yl propanones |
| 09/03/1997 | EP0792168A1 Novel tumor suppressor gene, hic-1 |
| 09/03/1997 | EP0792167A1 Monofunctional and/or polyfunctional polylysine conjugates |
| 09/03/1997 | EP0792160A1 Glial derived neurotrophic factor as a neuroprotective agent |
| 09/03/1997 | EP0792157A1 Preparation of mhc-peptide complexes |
| 09/03/1997 | EP0792156A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
| 09/03/1997 | EP0656905B1 Calcium channel blocking polypeptide from agelenopsis aperta |
| 09/03/1997 | EP0642337B1 Dapsone and promin for the treatment of dementia |
| 09/03/1997 | EP0581767B1 5H-DIBENZO(a,d)CYCLOHEPTENES AS MUSCARINIC RECEPTOR ANTAGONISTS |
| 09/03/1997 | CN1158639A DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme |
| 09/03/1997 | CN1158615A Bicyclic carboxamides as 5-ht1A antagonists |
| 09/03/1997 | CN1158610A Quinoxaline derivatives useful in therapy |
| 09/03/1997 | CN1158608A Certain aminomethyl phenylidazole derivatives, a new class of dopamine receptor subtype specific ligands |
| 09/02/1997 | US5663450 Promotes healing |
| 09/02/1997 | US5663449 For treating psychological disorders; analgesics |
| 09/02/1997 | US5663448 Treating alzheimer*s disease |
| 09/02/1997 | US5663380 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 09/02/1997 | US5663364 Heme binding compounds and use thereof |
| 09/02/1997 | US5663352 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
| 09/02/1997 | US5663349 Multistage process of reduction and amination of aminopyridines |
| 09/02/1997 | US5663345 Immunoregulatory, neuromuscular, joint and connective tissue disorders |
| 09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
| 09/02/1997 | US5663295 Analgesic, antidiarrhea |
| 09/02/1997 | US5663292 Antagonist peptides; regulation of secretion of corticotropin |
| 09/02/1997 | US5663204 Cholecystokinin and gastrin antagonist for appetite regulators, gastrointestinal disorders and nervous system disorders |
| 09/02/1997 | US5663202 Administering gamma-linolenic acid to reduce damage to gastrointestinal and nervous system during radiation therapy |
| 09/02/1997 | US5663201 Complexes with iron or aluminum |
| 09/02/1997 | US5663191 Psychiatric diseases, anxiety and antidepressants |
| 09/02/1997 | US5663190 Memory enhancing and analgesic 1,2,3,3a,8,8a-Hexahydro-3a,8(and 1,3a,8)-Di (and Tri)methylpyrrolo(2,3-b) indoles |
| 09/02/1997 | US5663184 Methods of inhibiting CNS problems in post-menopausal women |
| 09/02/1997 | US5663183 Cerebral disorders |
| 09/02/1997 | US5663173 Central nervous system disorders, cognition activators, pychoses, antidepressants and eating disorders |
| 09/02/1997 | US5663059 Polynucleotide with code, gene expression |
| 09/02/1997 | US5662920 Nicotine lozenge and therapeutic method for smoking cessation |
| 09/02/1997 | CA2146151C Method and use of melatonin to induce sleep |
| 09/01/1997 | CA2198687A1 Quinoxaline derivatives useful in therapy |
| 08/28/1997 | WO1997031002A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 08/28/1997 | WO1997030998A1 Azabicyclic esters of carbamic acids useful in therapy |
| 08/28/1997 | WO1997030997A1 Tropane-derivatives, their preparation and use |
| 08/28/1997 | WO1997030994A1 Oxa- and thia-diazole muscarinic receptor antagonists |
| 08/28/1997 | WO1997030977A1 Selective d1 dopamine receptor agonists and partial agonists/antagonists |
| 08/28/1997 | WO1997030722A1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders |
| 08/28/1997 | CA2247468A1 Selective d1 dopamine receptor agonists and partial agonists/antagonists |
| 08/28/1997 | CA2246051A1 Azabicyclic esters of carbamic acids useful in therapy |
| 08/28/1997 | CA2198571A1 Use of (e)-1-¬4'-(2-alkylaminoethioxy)phenyl|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions |
| 08/28/1997 | CA2198561A1 1,1,2-triphenylbut-1-ene derivatives for treating alzheimer's disease |
| 08/27/1997 | EP0791654A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes |
| 08/27/1997 | EP0791592A2 Azetidines |
| 08/27/1997 | EP0791355A1 Method of reducing tissue damage associated with ischemia |
| 08/27/1997 | EP0791067A2 Protein kinase npk-110 |
| 08/27/1997 | EP0791054A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease |
| 08/27/1997 | EP0791053A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases |